Home
HanAll BioPharma Co.

HanAll BioPharma Co. Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainhanall.co.kr

Year Founded1973

Employees201 - 500

Annual Revenue$100M - $200M

HanAll BioPharma Co.

HanAll BioPharma Co. (including company regionals)

hanall.co.kr

See more website traffic and engagement information

HanAll BioPharma Co. Revenue up to November 2025 is 100M - 200M

revenue generated by HanAll BioPharma Co. top domains

HanAll BioPharma Co. top domains revenue over 3 years

Revenue for HanAll BioPharma Co. top domains

hanall.co.kr100M - 200M

See more with Sales Intelligence

Total visits to HanAll BioPharma Co.'s top domains

Understand HanAll BioPharma Co. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

hanall.co.kr2.7K

See more with Sales Intelligence

Avg. visit duration in HanAll BioPharma Co.'s top domains

Analyze HanAll BioPharma Co. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

hanall.co.kr00:00:13

See more with Sales Intelligence

Avg. pageviews on HanAll BioPharma Co.'s top domains

See how HanAll BioPharma Co. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

hanall.co.kr1.31

See more with Sales Intelligence

HanAll BioPharma Co. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

genexine.comCompany NameGenexineEmployees51 - 200HQKorea, Republic of, Gyeonggi-doAnnual revenue$25M - $50MTotal visits3.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by HanAll BioPharma Co.

These are the website technologies, by industry, used by HanAll BioPharma Co. top domains

Social (2)

Instagram

Widget (2)

Google Maps

Advertising (1)

PubMatic

Mobile (1)

Meta Viewport

More Technologies

1

See all

News & Signals from HanAll BioPharma Co.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHanAll Pharmaceutical International hired Christopher Slavinsky as chief business development and legal officer on Jul 16th '24.Korean drugmaker HanAll Biopharma said Tuesday it has appointed Christopher Slavinsky, former Coherus BioSciences chief business and legal officer, as the chief business development and legal officer aiming to bolster global expansion efforts.

NewsHanAll Pharmaceutical International partners with Nurronpharma.Later, HanAll BioPharma and Daewoong Pharmaceutical collaborated with NurrOn Pharmaceuticals, initiating the administration of the first dose to a human participant in Phase 1 of clinical trials.

NewsDaewoong Pharmaceutical Co.,Ltd partnered with HanAll Pharmaceutical International on Jan 1st '23.NurrOn Pharmaceuticals began work on the potential treatment, under the name ATH-399A, and then partnered this year with HanAll Biopharma and Daewoong Pharmaceutical, both based in South Korea, to continue developing HL192.